News Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Delayed OTC Markets Other stock markets 10:26:21 2024-04-18 am EDT			5-day change	1st Jan Change
0.0002 ^USD	0.00%		-33.33%	0.00%

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	23-07-24	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23-01-23	CI
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-01-18	AQ
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	23-01-18	CI
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	23-01-17	MT
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	23-01-17	MT
Top Midday Decliners	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	23-01-17	MT
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	23-01-17	MT
Top Premarket Decliners	23-01-17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	23-01-17	MT
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K	23-01-17	PU
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	23-01-17	CI
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	23-01-17	AQ
Viveve Medical to Seek Strategic Alternatives	23-01-16	CI
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-12-15	AQ
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	22-12-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Summary

Filters